PRM162 Appropriate Comparative Treatments for Early Benefit Assessment (EBA) in Germany. Comparing the Suggestions by the Joint Federal Committee (GBA) and the Pharmaceutical Companies
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.1625
https://www.valueinhealthjournal.com/article/S1098-3015(12)03338-4/fulltext
Section Title :
Research on Methods
Section Order :
1120
First Page :
A490
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03338-4&doi=10.1016/j.jval.2012.08.1625